AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 141 min read$AZZ

AZZ Inc. Stock 12‑Month Price Target Cut to $161.6, Implies 18% Upside

AZZ Inc.'s average stock price target was reduced from $164 to $161.6 by 10 analysts, with a range of $140 to $200. This implies an 18% upside from the Oct. 13 closing price. The consensus rating remains 'Buy' among 12 analysts, with 6 'Buy' and 6 'Hold' ratings.

Original reporting
tradingview.com
Published Oct 14, 2026, 7:20 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 7:30 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AZZ Inc. Stock 12‑Month Price Target Cut to $161.6, Implies 18% Upside — source image
Source · tradingview.com
Decision brief

The 30-second read

$AZZBearishLow
01

Why it matters

The downgrade may trigger short‑term selling pressure but leaves an 18% upside based on the new target.

02

Market read

Analyst target revision offers a modest trading signal for AZZ shareholders.

03

What to watch

Potential upcoming product launches or contract wins not yet reflected in analyst models.

Relevance 5/10Novelty 5/10Timing: today

Background

AZZ Inc. is a specialty chemicals company; the article provides a brief analyst consensus update.

Company-level read

Ticker impact

$AZZBearishMedium confidence
Context

Analysts lowered AZZ's average price target to $161.6, down from $164, indicating a modest downgrade.

Expected impact

likely slight downside as investors price in the lower target

Evidence & confidence

A price‑target reduction signals weaker analyst outlook, which typically drags the share price in the short term.

Market effects

Sector

Minimal impact on the broader sector; only reflects analyst sentiment on AZZ.

Regional

Negligible effect on regional markets.

Global

Limited to investors tracking AZZ.

Counterpoint

What could challenge this read

Some traders may view the modest target cut as a buying opportunity if the stock is already undervalued.

Key entities

  • Company
    AZZ Inc.

    Specialty chemicals manufacturer

Read at source← All news

Related articles

OCT 26
$AZZMed

INVESTMENTTHESIS Why Own AZZ Five structural reasons why AZZ can compound shareholder returns and outperform the market over a multi-year horizon. Unrivaled…

AZZ INC (AZZ) filed an SEC Form 8-K — Regulation FD Disclosure. N Y S E : A Z Z | I N V E S T O R P R E S E N T A T I O N North America's Leading Independent Metal Coatings Platform A differentiated, high-margin hot-dip galvanizing and coil coating company, compounding earnings through secular tailwinds, disciplined capital allocation, and a

SEC EDGAR 8-K2 min
OCT 14
$AZZHighAI 8/10

AZZ Inc (AZZ) (Q2 2027) Earnings Call Highlights: Record Sales, Raised Guidance, and a 29% EPS Jump

AZZ Inc reported Q2 2027 earnings with record sales, raised guidance, and a 29% EPS jump. The company cited strong demand in Metal Coatings and the Seattle Galvanizing acquisition's performance. Challenges include softer HVAC volume, tight steel substrate markets, and potential margin pressure from tariffs. The debt reduction target was lowered to $100-$140 million due to the acquisition.

finance.yahoo.com2 min
OCT 14
$AZZMedAI 8/10

What AZZ (AZZ) Said on Its Q2 Earnings Call

AZZ Inc. reported Q2 earnings, highlighting the acquisition of Seattle Galvanizing and organic expansions. Sales grew in construction, industrial, and transportation sectors. The company raised its fiscal 2027 outlook, expecting sales of $1.825B-$1.875B and adjusted EBITDA of $380M-$420M. AZZ also updated its debt reduction target due to the acquisition.

finance.yahoo.com2 min
OCT 14
$AZZHighAI 8/10

AZZ (AZZ) Q2 2027 Earnings Call Transcript

AZZ reported Q2 2027 earnings with record sales of $486.9M, up 16.7% YoY. Metal Coatings sales rose 22.9%, while Precoat Metals sales increased 11.5%. Adjusted EPS grew 29% to $2.00. The company completed the Seattle Galvanizing acquisition and is expanding capacity in key markets. Operating cash flow was $102.8M, with adjusted EBITDA at $110.9M. The Washington, Missouri facility is ramping up as planned, contributing to profitability.

finance.yahoo.com3 min
OCT 14
$AZZMed

Barclays initiates AZZ stock with Equalweight rating on valuation

Barclays initiated coverage on AZZ Inc. (NYSE:AZZ) with an Equalweight rating and $140 price target, citing its market position and growth prospects. The stock trades at $136.71, below both the target and InvestingPro’s Fair Value of $139.07. Barclays noted AZZ’s pricing power, market share gains, and accretive greenfield plant, but believes positives are reflected in the share price.

investing.com1 min